Testosterone and Mood in Aging Men

Psychiatric Clinics of North America

Volumn 36, Issue 1, 2013, Pages 177-182

  Seidman, Stuart N ^a,c   Weiser, Mark ^b,c  

^a West End Medical Associates   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Depression; Hypothalamic pituitary gonadal axis; Partial androgen deficiency of aging male; Testosterone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

AGING; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; BONE MASS; COUGHING; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTOSIS; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INJECTION SITE PAIN; LIBIDO; MAJOR DEPRESSION; MOOD; MUSCLE MASS; OBESITY; PARTIAL ANDROGEN DEFICIENCY OF THE AGING MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; SEXUAL DYSFUNCTION; SKIN IRRITATION; SKIN MANIFESTATION; SLEEP DISORDER; AFFECT; DEPRESSION; MALE; PATHOPHYSIOLOGY; PSYCHOLOGY;

AFFECT; AGING; DEPRESSION; HUMANS; HYPOGONADISM; MALE; TESTOSTERONE;

EID: 84875624583     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2013.01.007     Document Type: Review

References (36)

1. Araujo A.B., Esche G.R., Kupelian V., et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007, 92:4241-4247.
2. Liu C.C., Wu W.J., Lee Y.C., et al. The prevalence of and risk factors for androgen deficiency in aging Taiwanese men. J Sex Med 2009, 6:936-946.
3. Seidman S.N. Androgens and the aging male. Psychopharmacol Bull 2007, 40:205-218.
4. Travison T.G., Shackelton R., Araujo A.B., et al. The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission. J Am Geriatr Soc 2008, 56:831-839.
5. Wang C., Nieschlag E., Swerdloff R., et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl 2009, 30:1-9.
6. Makinen J.I., Huhtaniemi I. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies-a mini-review. Gerontology 2011, 57:193-202.
7. Buvat J., Maggi M., Guay A., et al. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013, 10(1):245-284.
8. Spetz A.C., Palmefors L., Skobe R.S., et al. Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in an elderly Swedish population. Menopause 2007, 14:999-1005.
9. Chueh K.S., Huang S.P., Lee Y.C., et al. The comparison of the aging male symptoms (AMS) scale and androgen deficiency in the aging male (ADAM) questionnaire to detect androgen deficiency in middle-aged men. J Androl 2012, 33:817-823.
10. Emmelot-Vonk M.H., Verhaar H.J., Nakhai-Pour H.R., et al. Low testosterone concentrations and the symptoms of testosterone deficiency according to the androgen deficiency in ageing males (ADAM) and ageing males' symptoms rating scale (AMS) questionnaires. Clin Endocrinol (Oxf) 2011, 74:488-494.
11. Amore M., Innamorati M., Costi S., et al. Partial androgen deficiency, depression, and testosterone supplementation in aging men. Int J Endocrinol 2012, 2012:280724.
12. Wu F.C., Tajar A., Beynon J.M., et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010, 363:123-135.
13. Bassil N., Morley J.E. Late-life onset hypogonadism: a review. Clin Geriatr Med 2010, 26:197-222.
14. Rosen R.C., Araujo A.B., Connor M.K., et al. The NERI Hypogonadism Screener: psychometric validation in male patients and controls. Clin Endocrinol (Oxf) 2011, 74:248-256.
15. McKinlay J.B., Longcope C., Gray A. The questionable physiologic and epidemiologic basis for a male climacteric syndrome: preliminary results from the Massachusetts Male Aging Study. Maturitas 1989, 11:103-115.
16. Amiaz R., Seidman S.N. Testosterone and depression in men. Curr Opin Endocrinol Diabetes Obes 2008, 15:278-283.
17. Seidman S.N., Orr G., Raviv G., et al. Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial. J Clin Psychopharmacol 2009, 29:216-221.
18. Shores M.M., Kivlahan D.R., Sadak T.I., et al. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry 2009, 70:1009-1016.
19. Jockenhovel F., Minnemann T., Schubert M., et al. Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood. Aging Male 2009, 12:113-118.
20. Seidman S.N., Walsh B.T. Testosterone and depression in aging men. Am J Geriatr Psychiatry 1999, 7:18-33.
21. Seidman S.N., Rabkin J.G. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord 1998, 48:157-161.
22. Rabkin J.G., Wagner G.J., McElhiney M.C., et al. Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial. J Clin Psychopharmacol 2004, 24:379-385.
23. Seidman S.N., Spatz E., Rizzo C., et al. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 2001, 62:406-412.
24. Pope H.G., Cohane G.H., Kanayama G., et al. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003, 160:105-111.
25. Seidman S.N., Miyazaki M., Roose S.P. Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial. J Clin Psychopharmacol 2005, 25:584-588.
26. Orengo C.A., Fullerton L., Kunik M.E. Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy. J Geriatr Psychiatry Neurol 2005, 18:20-24.
27. Pope H.G., Amiaz R., Brennan B.P., et al. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol 2010, 30:126-134.
28. Bhasin S., Cunningham G.R., Hayes F.J., et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010, 95:2536-2559.
29. Bhasin S., Basaria S. Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab 2011, 25:251-270.
30. Bhasin S., Pencina M., Jasuja G.K., et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab 2011, 96:2430-2439.
31. Morgentaler A. Testosterone and prostate cancer: what are the risks for middle-aged men?. Urol Clin North Am 2011, 38:119-124.
32. Jannini E.A., Gravina G.L., Morgentaler A., et al. Is testosterone a friend or a foe of the prostate?. J Sex Med 2011, 8:946-955.
33. Basaria S., Coviello A.D., Travison T.G., et al. Adverse events associated with testosterone administration. N Engl J Med 2010, 363:109-122.
34. Amore M. Partial androgen deficiency and neuropsychiatric symptoms in aging men. J Endocrinol Invest 2005, 28:49-54.
35. Amiaz R., Pope H.G., Mahne T., et al. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther 2011, 37:243-254.
36. Emmelot-Vonk M.H., Verhaar Z.H., Nakhai-Pour H.A., et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008, 299:39-52.